Austria on the fast track The Whos Who of the biotech industry relies on Austria. Every second biotechnology company is located in the hotspot of Vienna, where a leading research centre the Campus Vienna BioCenter has … more ➔
Flexible. Reliable. Focussed. Richter-Helm is a leading and expanding Germany-based contract development and manufacturing organization (CDMO). Richter-Helm provides excellent services in the continuously growing market of pharmaceutical … more ➔
Accelerate development of adoptive cell th...The success of any adoptive cell therapy lies in how effectively and selectively engineered immune cells interact and kill cancer cells. Functional phenomics enables insights that can dramatically accelerate … more ➔
Bulletproof your supply chain This whitepaper provides insights into why it is critical to manage, optimize and streamline a supply chain to mitigate risks, such as those brought on by the COVID-19 pandemic. more ➔
Aseptic Closed Small-Volume Processing: To...Small-volume biopharmaceutical processes continue to grow as more biopharmaceutical, cell therapy and gene therapy companies develop products. A 2021 Association for Regenerative Medicine (ARM) report … more ➔
Let Excelya recruit the right people for t... Early phase clinical trials require expert support, often across many service areas and specialisms. Recruitment for trials can be complicated, with less flexibility and higher costs as you attempt … more ➔
What are the Ingredients of an mRNA Vaccin...mRNA technology has revolutionized vaccine development. What are the chemical components that make up a typical mRNA vaccine and what are their functions? What analytical testing can be done to support … more ➔
LKF 30 years dedicated to clinical tria...This year LKF Central Laboratory, which specialises in international clinical trials, celebrates its 30th anniversary. Although size and services have developed significantly since the beginning, … more ➔
Vaccine development – strategic appr... This white paper explores vaccine development during a pandemic, a response to complex challenges that traditional manufacturing methods won’t solve. more ➔
Drug repurposing trends shorten timelines This white paper explores the drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications. more ➔
